Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
    EC 2.1
    EC 2.2
    EC 2.3
    EC 2.4
    EC 2.5
    EC 2.6
    EC 2.7
      EC 2.7.1
        EC 2.7.1.1
        EC 2.7.1.2
        EC 2.7.1.3
        EC 2.7.1.4
        EC 2.7.1.5
        EC 2.7.1.6
        EC 2.7.1.7
        EC 2.7.1.8
        EC 2.7.1.9
        EC 2.7.1.10
        EC 2.7.1.11
        EC 2.7.1.12
        EC 2.7.1.13
        EC 2.7.1.14
        EC 2.7.1.15
        EC 2.7.1.16
        EC 2.7.1.17
        EC 2.7.1.18
        EC 2.7.1.19
        EC 2.7.1.20
        EC 2.7.1.21
        EC 2.7.1.22
        EC 2.7.1.23
        EC 2.7.1.24
        EC 2.7.1.25
        EC 2.7.1.26
        EC 2.7.1.27
        EC 2.7.1.28
        EC 2.7.1.29
        EC 2.7.1.30
        EC 2.7.1.31
        EC 2.7.1.32
        EC 2.7.1.33
        EC 2.7.1.34
        EC 2.7.1.35
        EC 2.7.1.36
        EC 2.7.1.37
        EC 2.7.1.38
        EC 2.7.1.39
        EC 2.7.1.40
        EC 2.7.1.41
        EC 2.7.1.42
        EC 2.7.1.43
        EC 2.7.1.44
        EC 2.7.1.45
        EC 2.7.1.46
        EC 2.7.1.47
        EC 2.7.1.48
        EC 2.7.1.49
        EC 2.7.1.50
        EC 2.7.1.51
        EC 2.7.1.52
        EC 2.7.1.53
        EC 2.7.1.54
        EC 2.7.1.55
        EC 2.7.1.56
        EC 2.7.1.57
        EC 2.7.1.58
        EC 2.7.1.59
        EC 2.7.1.60
        EC 2.7.1.61
        EC 2.7.1.62
        EC 2.7.1.63
        EC 2.7.1.64
        EC 2.7.1.65
        EC 2.7.1.66
        EC 2.7.1.67
        EC 2.7.1.68
        EC 2.7.1.69
        EC 2.7.1.70
        EC 2.7.1.71
        EC 2.7.1.72
        EC 2.7.1.73
        EC 2.7.1.74
        EC 2.7.1.75
        EC 2.7.1.76
        EC 2.7.1.77
        EC 2.7.1.78
        EC 2.7.1.79
        EC 2.7.1.80
        EC 2.7.1.81
        EC 2.7.1.82
        EC 2.7.1.83
        EC 2.7.1.84
        EC 2.7.1.85
        EC 2.7.1.86
        EC 2.7.1.87
        EC 2.7.1.88
        EC 2.7.1.89
        EC 2.7.1.90
        EC 2.7.1.91
        EC 2.7.1.92
        EC 2.7.1.93
        EC 2.7.1.94
        EC 2.7.1.95
        EC 2.7.1.96
        EC 2.7.1.97
        EC 2.7.1.98
        EC 2.7.1.99
        EC 2.7.1.100
        EC 2.7.1.101
        EC 2.7.1.102
        EC 2.7.1.103
        EC 2.7.1.104
        EC 2.7.1.105
        EC 2.7.1.106
        EC 2.7.1.107
        EC 2.7.1.108
        EC 2.7.1.109
        EC 2.7.1.110
        EC 2.7.1.111
        EC 2.7.1.112
        EC 2.7.1.113
        EC 2.7.1.114
        EC 2.7.1.115
        EC 2.7.1.116
        EC 2.7.1.117
        EC 2.7.1.118
        EC 2.7.1.119
        EC 2.7.1.120
        EC 2.7.1.121
        EC 2.7.1.122
        EC 2.7.1.123
        EC 2.7.1.124
        EC 2.7.1.125
        EC 2.7.1.126
        EC 2.7.1.127
        EC 2.7.1.128
        EC 2.7.1.129
        EC 2.7.1.130
        EC 2.7.1.131
        EC 2.7.1.132
        EC 2.7.1.133
        EC 2.7.1.134
        EC 2.7.1.135
        EC 2.7.1.136
        EC 2.7.1.137
        EC 2.7.1.138
        EC 2.7.1.139
        EC 2.7.1.140
        EC 2.7.1.141
        EC 2.7.1.142
        EC 2.7.1.143
        EC 2.7.1.144
        EC 2.7.1.145
        EC 2.7.1.146
        EC 2.7.1.147
        EC 2.7.1.148
        EC 2.7.1.149
        EC 2.7.1.150
        EC 2.7.1.151
        EC 2.7.1.152
        EC 2.7.1.153
        EC 2.7.1.154
        EC 2.7.1.155
        EC 2.7.1.156
        EC 2.7.1.157
        EC 2.7.1.158
        EC 2.7.1.159
        EC 2.7.1.160
        EC 2.7.1.161
        EC 2.7.1.162
      EC 2.7.2
      EC 2.7.3
      EC 2.7.4
      EC 2.7.5
      EC 2.7.6
      EC 2.7.7
      EC 2.7.8
      EC 2.7.9
      EC 2.7.10
      EC 2.7.11
      EC 2.7.12
      EC 2.7.13
      EC 2.7.14
    EC 2.8
    EC 2.9
  EC 3: Hydrolases
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 2.7.1.37 - obsolete, now divided into EC 2.7.11.1, EC 2.7.11.8, EC 2.7.11.9, EC 2.7.11.10, EC 2.7.11.11, EC 2.7.11.12, EC 2.7.11.13, EC 2.7.11.21, EC 2.7.11.22, EC 2.7.11.24, EC 2.7.11.25, EC 2.7.11.30 and EC 2.7.12.1



3D structures of EC 2.7.1.37 in Protein Data Bank

updated: 29 May 2015, 1:12

In total: 423 PDB structures of EC 2.7.1.37:
  1. 1apm: 2.0 Angstrom Refined Crystal Structure of The Catalytic Subunit of Camp-dependent Protein Kinase Complexed with a Peptide Inhibitor and Detergent
  2. 1aq1: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor Staurosporine
  3. 1atp: 2.2 Angstrom Refined Crystal Structure of The Catalytic Subunit of Camp-dependent Protein Kinase Complexed with Mnatp and a Peptide Inhibitor
  4. 1b38: Human Cyclin-dependent Kinase 2
  5. 1b39: Human Cyclin-dependent Kinase 2 Phosphorylated on Thr 160
  6. 1b6c: Crystal Structure of The Cytoplasmic Domain of The Type I Tgf-beta Receptor in Complex with Fkbp12
  7. 1bdy: C2 Domain from Protein Kinase C Delta
  8. 1bkx: A Binary Complex of The Catalytic Subunit of Camp-dependent Protein Kinase and Adenosine Further Defines Conformational Flexibility
  9. 1bx6: Crystal Structure of The Potent Natural Product Inhibitor Balanol in Complex with The Catalytic Subunit of Camp- Dependent Protein Kinase
  10. 1cdk: Camp-dependent Protein Kinase Catalytic Subunit (e.c.2.7.1.37) (protein Kinase A) Complexed with Protein Kinase Inhibitor Peptide Fragment 5-24 (pki(5-24) Isoelectric Variant Ca) and Mn2+ Adenylyl Imidodiphosphate (mnamp-pnp) at Ph 5.6 and 7c and 4c
  11. 1ckp: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor Purvalanol B
  12. 1cmk: Crystal Structures of The Myristylated Catalytic Subunit of Camp-dependent Protein Kinase Reveal Open and Closed Conformations
  13. 1ctp: Structure of The Mammalian Catalytic Subunit of Camp- Dependent Protein Kinase and an Inhibitor Peptide Displays an Open Conformation
  14. 1daw: Crystal Structure of a Binary Complex of Protein Kinase Ck2 (alpha-subunit) and Mg-amppnp
  15. 1day: Crystal Structure of a Binary Complex of Protein Kinase Ck2 (alpha-subunit) and Mg-gmppnp
  16. 1ddm: Solution Structure of The Numb Ptb Domain Complexed to a Nak Peptide
  17. 1ds5: Dimeric Crystal Structure of The Alpha Subunit in Complex with Two Beta Peptides Mimicking The Architecture of The Tetrameric Protein Kinase Ck2 Holoenzyme.
  18. 1e1v: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor Nu2058
  19. 1e1x: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor Nu6027
  20. 1e9h: Thr 160 Phosphorylated Cdk2 - Human Cyclin A3 Complex with The Inhibitor Indirubin-5-sulphonate Bound
  21. 1f0q: Crystal Structure of The Alpha Subunit of Protein Kinase Ck2 in Complex with The Nucleotide Competitive Inhibitor Emodin
  22. 1fmo: Crystal Structure of a Polyhistidine-tagged Recombinant Catalytic Subunit of Camp-dependent Protein Kinase Complexed with The Peptide Inhibitor Pki(5-24) and Adenosine
  23. 1fot: Structure of The Unliganded Camp-dependent Protein Kinase Catalytic Subunit from Saccharomyces Cerevisiae
  24. 1fvt: The Structure of Cyclin-dependent Kinase 2 (cdk2) in Complex with an Oxindole Inhibitor
  25. 1fvv: The Structure of Cdk2/cyclin a in Complex with an Oxindole Inhibitor
  26. 1g3n: Structure of a P18(INK4C)-CDK6-K-CYCLIN Ternary Complex
  27. 1gih: Human Cyclin Dependent Kinase 2 Complexed with The Cdk4 Inhibitor
  28. 1gii: Human Cyclin Dependent Kinase 2 Complexed with The Cdk4 Inhibitor
  29. 1gij: Human Cyclin Dependent Kinase 2 Complexed with The Cdk4 Inhibitor
  30. 1gng: Glycogen Synthase Kinase-3 Beta (gsk3) Complex with Frattide Peptide
  31. 1gz8: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor 2-amino-6-(3'-methyl-2'-oxo)butoxypurine
  32. 1h00: Cdk2 in Complex with a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor
  33. 1h01: Cdk2 in Complex with a Disubstituted 2, 4-bis Anilino Pyrimidine Cdk4 Inhibitor
  34. 1h07: Cdk2 in Complex with a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor
  35. 1h08: Cdk2 in Complex with a Disubstituted 2, 4-bis Anilino Pyrimidine Cdk4 Inhibitor
  36. 1h0v: Human Cyclin Dependent Protein Kinase 2 in Complex with The Inhibitor 2-amino-6-[(r)-pyrrolidino-5'-yl]methoxypurine
  37. 1h0w: Human Cyclin Dependent Protein Kinase 2 in Complex with The Inhibitor 2-amino-6-[cyclohex-3-enyl]methoxypurine
  38. 1h1w: High Resolution Crystal Structure of The Human Pdk1 Catalytic Domain
  39. 1h8f: Glycogen Synthase Kinase 3 Beta.
  40. 1hck: Human Cyclin-dependent Kinase 2
  41. 1hcl: Human Cyclin-dependent Kinase 2
  42. 1i09: Structure of Glycogen Synthase Kinase-3 (GSK3B)
  43. 1ia9: Crystal Structure of The Atypical Protein Kinase Domain of a Trp Ca-channel, Chak (amppnp Complex)
  44. 1iah: Crystal Structure of The Atypical Protein Kinase Domain of a Trp Ca-channel, Chak (adp-mg Complex)
  45. 1iaj: Crystal Structure of The Atypical Protein Kinase Domain of a Trp Ca-channel, Chak (apo)
  46. 1ias: Cytoplasmic Domain of Unphosphorylated Type I Tgf-beta Receptor Crystallized without Fkbp12
  47. 1id0: Crystal Structure of The Nucleotide Bond Conformation of Phoq Kinase Domain
  48. 1ik7: Crystal Structure of The Uncomplexed Pelle Death Domain
  49. 1j1b: Binary Complex Structure of Human Tau Protein Kinase I with Amppnp
  50. 1j1c: Binary Complex Structure of Human Tau Protein Kinase I with Adp
  51. 1j3h: Crystal Structure of Apoenzyme Camp-dependent Protein Kinase Catalytic Subunit
  52. 1j91: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 4,5,6,7- Tetrabromobenzotriazole
  53. 1jam: Crystal Structure of Apo-form of Z. Mays Ck2 Protein Kinase Alpha Subunit
  54. 1jbp: Crystal Structure of The Catalytic Subunit of Camp- Dependent Protein Kinase Complexed with a Substrate Peptide, Adp and Detergent
  55. 1jlu: Crystal Structure of The Catalytic Subunit of Camp- Dependent Protein Kinase Complexed with a Phosphorylated Substrate Peptide and Detergent
  56. 1jvp: Crystal Structure of Human Cdk2 (unphosphorylated) in Complex with Pkf049-365
  57. 1jwh: Crystal Structure of Human Protein Kinase Ck2 Holoenzyme
  58. 1ke5: Cdk2 Complexed with N-methyl-4-{[(2-oxo-1,2-dihydro-3h- Indol-3-ylidene)methyl]amino}benzenesulfonamide
  59. 1ke6: Cyclin-dependent Kinase 2 (cdk2) Complexed with N-methyl-{4- [2-(7-oxo-6,7-dihydro-8h-[1,3]thiazolo[5,4-e]indol-8- Ylidene)hydrazino]phenyl}methanesulfonamide
  60. 1ke7: Cyclin-dependent Kinase 2 (cdk2) Complexed with 3-{[(2,2- Dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5- (1,3-oxazol-5-yl)-1,3-dihydro-2h-indol-2-one
  61. 1ke8: Cyclin-dependent Kinase 2 (cdk2) Complexed with 4-{[(2-oxo- 1,2-dihydro-3h-indol-3-ylidene)methyl]amino}-n-(1,3- Thiazol-2-yl)benzenesulfonamide
  62. 1ke9: Cyclin-dependent Kinase 2 (cdk2) Complexed with 3-{[4- ({[amino(imino)methyl]aminosulfonyl)anilino]methylene}-2- Oxo-2,3-dihydro-1h-indole
  63. 1ktz: Crystal Structure of The Human Tgf-beta Type II Receptor Extracellular Domain in Complex with Tgf-beta3
  64. 1l3r: Crystal Structure of a Transition State Mimic of The Catalytic Subunit of Camp-dependent Protein Kinase
  65. 1l6e: Solution Structure of The Docking and Dimerization Domain of Protein Kinase a Ii-alpha (riialpha D/d). Alternatively Called The N-terminal Dimerization Domain of The Regulatory Subunit of Protein Kinase A.
  66. 1ll8: Structure and Interactions of Pas Kinase N-terminal Pas Domain: Model for Intramolecular Kinase Regulation
  67. 1lp4: Crystal Structure of a Binary Complex of The Catalytic Subunit of Protein Kinase Ck2 with Mg-amppnp
  68. 1lpu: Low Temperature Crystal Structure of The Apo-form of The Catalytic Subunit of Protein Kinase Ck2 from Zea Mays
  69. 1lr4: Room Temperature Crystal Structure of The Apo-form of The Catalytic Subunit of Protein Kinase Ck2 from Zea Mays
  70. 1m2p: Crystal Structure of 1,8-di-hydroxy-4-nitro- Anthraquinone/ck2 Kinase Complex
  71. 1m2q: Crystal Structure of 1,8-di-hydroxy-4-nitro-xanten-9- One/ck2 Kinase Complex
  72. 1m2r: Crystal Structure of 5,8-di-amino-1,4-di-hydroxy- Anthraquinone/ck2 Kinase Complex
  73. 1mby: Murine Sak Polo Domain
  74. 1na7: Crystal Structure of The Catalytic Subunit of Human Protein Kinase Ck2
  75. 1o6k: Structure of Activated Form of Pkb Kinase Domain S474D with Gsk3 Peptide and Amp-pnp
  76. 1o6l: Crystal Structure of an Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex with Amp-pnp and Gsk3 Peptide
  77. 1o6y: Catalytic Domain of Pknb Kinase from Mycobacterium Tuberculosis
  78. 1o9u: Glycogen Synthase Kinase 3 Beta Complexed with Axin Peptide
  79. 1ogu: Structure of Human Thr160-phospho Cdk2/cyclin a Complexed with a 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine Inhibitor
  80. 1oi9: Structure of Human Thr160-phospho Cdk2/cyclin a Complexed with a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor
  81. 1oiq: Imidazopyridines: a Potent and Selective Class of Cyclin-dependent Kinase Inhibitors Identified through Structure-based Hybridisation
  82. 1oir: Imidazopyridines: a Potent and Selective Class of Cyclin-dependent Kinase Inhibitors Identified through Structure-based Hybridisation
  83. 1oit: Imidazopyridines: a Potent and Selective Class of Cyclin-dependent Kinase Inhibitors Identified through Structure-based Hybridisation
  84. 1oiu: Structure of Human Thr160-phospho Cdk2/cyclin a Complexed with a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor
  85. 1oiy: Structure of Human Thr160-phospho Cdk2/cyclin a Complexed with a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor
  86. 1okv: Cyclin a Binding Groove Inhibitor H-arg-arg-leu-ile-phe-nh2
  87. 1okw: Cyclin a Binding Groove Inhibitor Ac-arg-arg-leu-asn- (m-cl-phe)-nh2
  88. 1oky: Structure of Human Pdk1 Kinase Domain in Complex with Staurosporine
  89. 1okz: Structure of Human Pdk1 Kinase Domain in Complex with Ucn-01
  90. 1ol1: Cyclin a Binding Groove Inhibitor H-cit-cit-leu-ile- (p-f-phe)-nh2
  91. 1ol2: Cyclin a Binding Groove Inhibitor H-arg-arg-leu-asn- (p-f-phe)-nh2
  92. 1ol5: Structure of Aurora-a 122-403, Phosphorylated on Thr287, Thr288 and Bound to Tpx2 1-43
  93. 1ol6: Structure of Unphosphorylated D274N Mutant of Aurora-a
  94. 1ol7: Structure of Human Aurora-a 122-403 Phosphorylated on Thr287, Thr288
  95. 1om1: Crystal Structure of Maize Ck2 Alpha in Complex with Iqa
  96. 1ouk: The Structure of P38 Alpha in Complex with a Pyridinylimidazole Inhibitor
  97. 1ouy: The Structure of P38 Alpha in Complex with a Dihydropyrido- Pyrimidine Inhibitor
  98. 1ove: The Structure of P38 Alpha in Complex with a Dihydroquinolinone
  99. 1oz1: P38 Mitogen-activated Kinase in Complex with 4-azaindole Inhibitor
  100. 1pf8: Crystal Structure of Human Cyclin-dependent Kinase 2 Complexed with a Nucleoside Inhibitor
  101. 1pjk: Crystal Structure of a C-terminal Deletion Mutant of Human Protein Kinase Ck2 Catalytic Subunit
  102. 1plo: Transforming Growth Factor-beta Type II Receptor Extracellular Domain
  103. 1py5: Crystal Structure of Tgf-beta Receptor I Kinase with Inhibitor
  104. 1pyx: Gsk-3 Beta Complexed with Amp-pnp
  105. 1q24: Pka Double Mutant Model of Pkb in Complex with Mgatp
  106. 1q3d: Gsk-3 Beta Complexed with Staurosporine
  107. 1q3w: Gsk-3 Beta Complexed with Alsterpaullone
  108. 1q41: Gsk-3 Beta Complexed with Indirubin-3'-monoxime
  109. 1q4l: Gsk-3 Beta Complexed with Inhibitor I-5
  110. 1q5k: Crystal Structure of Glycogen Synthase Kinase 3 in Complexed with Inhibitor
  111. 1q61: Pka Triple Mutant Model of Pkb
  112. 1q62: Pka Double Mutant Model of Pkb
  113. 1q8t: The Catalytic Subunit of Camp-dependent Protein Kinase (pka) in Complex with Rho-kinase Inhibitor Y-27632
  114. 1q8u: The Catalytic Subunit of Camp-dependent Protein Kinase in Complex with Rho-kinase Inhibitor H-1152p
  115. 1q8w: The Catalytic Subunit of Camp-dependent Protein Kinase in Complex with Rho-kinase Inhibitor Fasudil (ha-1077)
  116. 1qf8: Truncated Form of Casein Kinase II Beta Subunit (2-182) from Homo Sapiens
  117. 1r0e: Glycogen Synthase Kinase-3 Beta in Complex with 3-indolyl-4- Arylmaleimide Inhibitor
  118. 1r2a: The Molecular Basis for Protein Kinase a Anchoring Revealed by Solution Nmr
  119. 1r39: The Structure of P38ALPHA
  120. 1r3c: The Structure of P38ALPHA C162S Mutant
  121. 1rdq: Hydrolysis of Atp in The Crystal of Y204A Mutant of Camp- Dependent Protein Kinase
  122. 1re8: Crystal Structure of Camp-dependent Protein Kinase Complexed with Balanol Analog 2
  123. 1rej: Crystal Structure of Camp-dependent Protein Kinase Complexed with Balanol Analog 1
  124. 1rek: Crystal Structure of Camp-dependent Protein Kinase Complexed with Balanol Analog 8
  125. 1rew: Structural Refinement of The Complex of Bone Morphogenetic Protein 2 and Its Type Ia Receptor
  126. 1rgs: Regulatory Subunit of Camp Dependent Protein Kinase
  127. 1rqf: Structure of Ck2 Beta Subunit Crystallized in The Presence of a P21WAF1 Peptide
  128. 1rw8: Crystal Structure of Tgf-beta Receptor I Kinase with Atp Site Inhibitor
  129. 1rwi: Extracellular Domain of Mycobacterium Tuberculosis Pknd
  130. 1rwl: Extracellular Domain of Mycobacterium Tuberculosis Pknd
  131. 1s4y: Crystal Structure of The Activin/actriib Extracellular Domain
  132. 1s9i: X-ray Structure of The Human Mitogen-activated Protein Kinase Kinase 2 (mek2)in a Complex with Ligand and Mgatp
  133. 1s9j: X-ray Structure of The Human Mitogen-activated Protein Kinase Kinase 1 (mek1) in a Complex with Ligand and Mgatp
  134. 1smh: Protein Kinase a Variant Complex with Completely Ordered N- Terminal Helix
  135. 1stc: Camp-dependent Protein Kinase, Alpha-catalytic Subunit in Complex with Staurosporine
  136. 1sve: Crystal Structure of Protein Kinase a in Complex with Azepane Derivative 1
  137. 1svg: Crystal Structure of Protein Kinase a in Complex with Azepane Derivative 4
  138. 1svh: Crystal Structure of Protein Kinase a in Complex with Azepane Derivative 8
  139. 1syk: Crystal Structure of E230Q Mutant of Camp-dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation
  140. 1szm: Dual Binding Mode of Bisindolylmaleimide 2 to Protein Kinase a (pka)
  141. 1th8: Crystal Structures of The Adp and Atp Bound Forms of The Bacillus Anti-sigma Factor Spoiiab in Complex with The Anti-anti-sigma Spoiiaa: Inhibitory Complex with Adp, Crystal Form II
  142. 1thn: Crystal Structures of The Adp and Atp Bound Forms of The Bacillus Anti-sigma Factor Spoiiab in Complex with The Anti-anti-sigma Spoiiaa: Inhibitory Complex with Adp, Crystal Form I
  143. 1tid: Crystal Structures of The Adp and Atp Bound Forms of The Bacillus Anti-sigma Factor Spoiiab in Complex with The Anti-anti-sigma Spoiiaa: Poised for Phosphorylation Complex with Atp, Crystal Form I
  144. 1til: Crystal Structures of The Adp and Atp Bound Forms of The Bacillus Anti-sigma Factor Spoiiab in Complex with The Anti-anti-sigma Spoiiaa:poised for Phosphorylation Complex with Atp, Crystal Form II
  145. 3e3p: Glycogen Synthase Kinase from Leishmania Major
  146. 1tvo: The Structure of Erk2 in Complex with a Small Molecule Inhibitor
  147. 1ua2: Crystal Structure of Human Cdk7
  148. 1ukh: Structural Basis for The Selective Inhibition of Jnk1 by The Scaffolding Protein Jip1 and Sp600125
  149. 1uki: Structural Basis for The Selective Inhibition of Jnk1 by The Scaffolding Protein Jip1 and Sp600125
  150. 1urc: Cyclin a Binding Groove Inhibitor Ace-arg-lys-leu- Phe-gly
  151. 1urw: Cdk2 in Complex with an Imidazo[1,2-b]pyridazine
  152. 1uti: Mona/gads SH3C in Complex with Hpk Derived Peptide
  153. 1uu3: Structure of Human Pdk1 Kinase Domain in Complex with Ly333531
  154. 1uu7: Structure of Human Pdk1 Kinase Domain in Complex with Bim-2
  155. 1uu8: Structure of Human Pdk1 Kinase Domain in Complex with Bim-1
  156. 1uu9: Structure of Human Pdk1 Kinase Domain in Complex with Bim-3
  157. 1uv5: Glycogen Synthase Kinase 3 Beta Complexed with 6-bromoindirubin-3'-oxime
  158. 1uvr: Structure of Human Pdk1 Kinase Domain in Complex with Bim-8
  159. 1uwh: The Complex of Wild Type B-raf and Bay439006
  160. 1uwj: The Complex of Mutant V599E B-raf and Bay439006
  161. 1v1k: Cdk2 in Complex with a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor
  162. 1vd2: Solution Structure of The Pb1 Domain of Pkciota
  163. 1veb: Crystal Structure of Protein Kinase a in Complex with Azepane Derivative 5
  164. 1vjy: Crystal Structure of a Naphthyridine Inhibitor of Human Tgf- Beta Type I Receptor
  165. 1vyw: Structure of Cdk2/cyclin a with Pnu-292137
  166. 1vyz: Structure of Cdk2 Complexed with Pnu-181227
  167. 1vzo: The Structure of The N-terminal Kinase Domain of Msk1 Reveals a Novel Autoinhibitory Conformation for a Dual Kinase Protein
  168. 1w0x: Crystals Structure of Human Cdk2 in Complex with The Inhibitor Olomoucine.
  169. 1w1d: Crystal Structure of The Pdk1 Pleckstrin Homology (ph) Domain Bound to Inositol (1,3,4,5)-tetrakisphosphate
  170. 1w1g: Crystal Structure of The Pdk1 Pleckstrin Homology (ph) Domain Bound to Dic4-phosphatidylinositol (3,4,5)- Trisphosphate
  171. 1w1h: Crystal Structure of The Pdk1 Pleckstrin Homology (ph) Domain
  172. 1w7h: P38 Kinase Crystal Structure in Complex with Small Molecule Inhibitor
  173. 1w82: P38 Kinase Crystal Structure in Complex with Small Molecule Inhibitor
  174. 1w83: P38 Kinase Crystal Structure in Complex with Small Molecule Inhibitor
  175. 1w84: P38 Kinase Crystal Structure in Complex with Small Molecule Inhibitor
  176. 1w8c: Co-crystal Structure of 6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine and Monomeric Cdk2
  177. 1w98: The Structural Basis of Cdk2 Activation by Cyclin E
  178. 1wak: X-ray Structure of Srpk1
  179. 1wbn: Fragment Based P38 Inhibitors
  180. 1wbo: Fragment Based P38 Inhibitors
  181. 1wbp: Srpk1 Bound to 9mer Docking Motif Peptide
  182. 1wbs: Identification of Novel P38 Alpha Map Kinase Inhibitors Using Fragment-based Lead Generation.
  183. 1wbt: Identification of Novel P38 Alpha Map Kinase Inhibitors Using Fragment-based Lead Generation.
  184. 1wbv: Identification of Novel P38 Alpha Map Kinase Inhibitors Using Fragment-based Lead Generation.
  185. 1wbw: Identification of Novel P38 Alpha Map Kinase Inhibitors Using Fragment-based Lead Generation.
  186. 1wcc: Screening for Fragment Binding by X-ray Crystallography
  187. 1wh4: Solution Structure of The Death Domain of Interleukin-1 Receptor-associated Kinase4 (irak4) from Mus Musculus
  188. 1wmh: Crystal Structure of a Pb1 Domain Complex of Protein Kinase C Iota and Par6 Alpha
  189. 1wmk: Human Death-associated Kinase Drp-1, Mutant S308D D40
  190. 1wrz: Calmodulin Complexed with a Peptide from a Human Death- Associated Protein Kinase
  191. 1wvw: Crystal Structures of Kinase Domain of Dap Kinase in Complex with Small Molecular Inhibitors
  192. 1wvx: Crystal Structures of Kinase Domain of Dap Kinase in Complex with Small Molecular Inhibitors
  193. 1wvy: Crystal Structures of Kinase Domain of Dap Kinase in Complex with Small Molecular Inhibitors
  194. 1wxm: Solution Structure of The N-terminal Ras-binding Domain (rbd) in Human A-raf Kinase
  195. 1wzy: Crystal Structure of Human Erk2 Complexed with a Pyrazolopyridazine Derivative
  196. 1x9x: Solution Structure of Dimeric Sam Domain from Mapkkk Ste11
  197. 1xh4: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  198. 1xh5: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  199. 1xh6: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  200. 1xh7: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  201. 1xh8: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  202. 1xh9: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  203. 1xha: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  204. 2xmy: Discovery and Characterisation of 2-anilino-4-(thiazol-5-yl) Pyrimidine Transcriptional Cdk Inhibitors as Anticancer Agents
  205. 1xo2: Crystal Structure of a Human Cyclin-dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin
  206. 1xqz: Crystal Structure of Hpim-1 Kinase at 2.1 a Resolution
  207. 1xr1: Crystal Structure of Hpim-1 Kinase in Complex with Amp-pnp at 2.1 a Resolution
  208. 1xte: Crystal Structure of Cisk-px Domain
  209. 1xtn: Crystal Structure of Cisk-px Domain with Sulfates
  210. 1xws: Crystal Structure of The Human Pim1 Kinase Domain
  211. 2x1n: Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a through Structure Guided Design
  212. 1y8g: Catalytic and Ubiqutin-associated Domains of Mark2/par-1: Inactive Double Mutant with Selenomethionine
  213. 2wxv: Structure of Cdk2-cyclin a with a Pyrazolo(4,3-h) Quinazoline-3-carboxamide Inhibitor
  214. 1y8y: Crystal Structure of Human Cdk2 Complexed with a Pyrazolo[1, 5-a]pyrimidine Inhibitor
  215. 1y91: Crystal Structure of Human Cdk2 Complexed with a Pyrazolo[1, 5-a]pyrimidine Inhibitor
  216. 1ydr: Structure of Camp-dependent Protein Kinase, Alpha-catalytic Subunit in Complex with H7 Protein Kinase Inhibitor 1-(5- Isoquinolinesulfonyl)-2-methylpiperazine
  217. 1yds: Structure of Camp-dependent Protein Kinase, Alpha-catalytic Subunit in Complex with H8 Protein Kinase Inhibitor [n-(2- Methylamino)ethyl]-5-isoquinolinesulfonamide
  218. 1ydt: Structure of Camp-dependent Protein Kinase, Alpha-catalytic Subunit in Complex with H89 Protein Kinase Inhibitor N-[2- (4-bromocinnamylamino)ethyl]-5-isoquinoline
  219. 1ygo: Solution Structure of The Pelle Death Domain
  220. 1yhs: Crystal Structure of Pim-1 Bound to Staurosporine
  221. 1yhv: Crystal Structure of Pak1 Kinase Domain with Two Point Mutations (K299R, T423E)
  222. 1yhw: Crystal Structure of Pak1 Kinase Domain with One Point Mutations (K299R)
  223. 1yi3: Crystal Structure of Pim-1 Bound to Ly294002
  224. 1yi4: Structure of Pim-1 Bound to Adenosine
  225. 2wpa: Optimisation of 6,6-dimethyl Pyrrolo 3,4-c Pyrazoles: Identification of Pha-793887, a Potent Cdk Inhibitor Suitable for Intravenous Dosing
  226. 1ykr: Crystal Structure of Cdk2 with an Aminoimidazo Pyridine Inhibitor
  227. 1yqj: Crystal Structure of P38 Alpha in Complex with a Selective Pyridazine Inhibitor
  228. 1yr5: 1.7-a Structure of Calmodulin Bound to a Peptide from Dap Kinase
  229. 1yrp: Catalytic Domain of Human Zip Kinase Phosphorylated at Thr265
  230. 2wip: Structure of Cdk2-cyclin a Complexed with 8-anilino-1- Methyl-4,5-dihydro-1h-pyrazolo[4,3-h] Quinazoline-3- Carboxylic Acid
  231. 2wih: Structure of Cdk2-cyclin a with Pha-848125
  232. 2whb: Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a through Structure Guided Design
  233. 1yw2: Mutated Mus Musculus P38 Kinase (mp38)
  234. 1ywr: Crystal Structure Analysis of Inactive P38 Kinase Domain in Complex with a Monocyclic Pyrazolone Inhibitor
  235. 1ywv: Crystal Structures of Proto-oncogene Kinase Pim1: a Target of Aberrant Somatic Hypermutations in Diffuse Large Cell Lymphoma
  236. 2wfy: Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a through Structure Guided Design
  237. 2wev: Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a through Structure Guided Design
  238. 1yxs: Crystal Structure of Kinase Pim1 with P123M Mutation
  239. 1yxt: Crystal Structure of Kinase Pim1 in Complex with Amppnp
  240. 1yxu: Crystal Structure of Kinase Pim1 in Complex with Amp
  241. 1yxv: Crystal Structure of Kinase Pim1 in Complex with 3,4- Dihydroxy-1-methylquinolin-2(1h)-one
  242. 1yxx: Crystal Structure of Kinase Pim1 in Complex with (3e)-3-[(4- Hydroxyphenyl)imino]-1h-indol-2(3h)-one
  243. 1z57: Crystal Structure of Human Clk1 in Complex with 10z- Hymenialdisine
  244. 1z5m: Crystal Structure of N1-[3-[[5-bromo-2-[[3-[(1- Pyrrolidinylcarbonyl)amino]phenyl]amino]-4- Pyrimidinyl]amino]propyl]-2,2-dimethylpropanediamide Complexed with Human Pdk1
  245. 1z9x: Human Drp-1 Kinase, W305S S308A D40 Mutant, Crystal Form with 3 Monomers in The Asymmetric Unit
  246. 2w1h: Fragment-based Discovery of The Pyrazol-4-yl Urea (at9283), a Multi-targeted Kinase Inhibitor with Potent Aurora Kinase Activity
  247. 1zlt: Crystal Structure of Chk1 Complexed with a Hymenaldisine Analog
  248. 1zmu: Catalytic and Ubiqutin-associated Domains of Mark2/par-1: Wild Type
  249. 1zmv: Catalytic and Ubiqutin-associated Domains of Mark2/par-1: K82R Mutant
  250. 1zmw: Catalytic and Ubiqutin-associated Domains of Mark2/par-1: T208A/S212A Inactive Double Mutant
  251. 1zoe: Crystal Structure of Protein Kinase Ck2 in Complex with Tbb- Derivatives Inhibitors
  252. 1zog: Crystal Structure of Protein Kinase Ck2 in Complex with Tbb- Derivatives
  253. 1zoh: Crystal Structure of Protein Kinase Ck2 in Complex with Tbb- Derivatives Inhibitors
  254. 1zsg: Beta Pix-sh3 Complexed with an Atypical Peptide from Alpha- Pak
  255. 1zxa: Solution Structure of The Coiled-coil Domain of Cgmp- Dependent Protein Kinase Ia
  256. 1zxe: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: D835N Inactivating Mutant in Apo Form
  257. 1zy4: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: R794G Hyperactivating Mutant in Apo Form.
  258. 1zy5: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: R794G Hyperactivating Mutant Complexed with Amppnp.
  259. 1zyc: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: Wild- Type in Apo Form.
  260. 1zyd: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: Wild- Type Complexed with Atp.
  261. 1zyj: Human P38 Map Kinase in Complex with Inhibitor 1a
  262. 1zys: Co-crystal Structure of Checkpoint Kinase Chk1 with a Pyrrolo-pyridine Inhibitor
  263. 1zz2: Two Classes of P38ALPHA Map Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes
  264. 1zzl: Crystal Structure of P38 with Triazolopyridine
  265. 2a0c: Human Cdk2 in Complex with Olomoucine Ii, a Novel 2,6,9- Trisubstituted Purine Cyclin-dependent Kinase Inhibitor
  266. 2a0t: Nmr Structure of The Fha1 Domain of Rad53 in Complex with a Biological Relevant Phosphopeptide Derived from Madt1
  267. 2a27: Human Drp-1 Kinase, W305S S308A D40 Mutant, Crystal Form with 8 Monomers in The Asymmetric Unit
  268. 2a2a: High-resolution Crystallographic Analysis of The Autoinhibited Conformation of a Human Death-associated Protein Kinase
  269. 2a4l: Human Cyclin-dependent Kinase 2 in Complex with Roscovitine
  270. 2a9i: Molecular Structure of The Interleukin-1 Receptor- Associated Kinase-4 Death Domain
  271. 2ac3: Structure of Human Mnk2 Kinase Domain
  272. 2ac5: Structure of Human Mnk2 Kinase Domain Mutant D228G
  273. 2v22: Replace: a Strategy for Iterative Design of Cyclin Binding Groove Inhibitors
  274. 2v0d: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  275. 2uzo: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  276. 2uzn: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  277. 2uzl: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  278. 2uze: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  279. 2uzd: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  280. 2uzb: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  281. 2ayp: Crystal Structure of Chk1 with an Indol Inhibitor
  282. 2b1p: Inhibitor Complex of Jnk3
  283. 2b52: Human Cyclin Dependent Kinase 2 (cdk2) Complexed with Dph- 042562
  284. 2b53: Human Cyclin Dependent Kinase 2 (cdk2) Complexed with Din- 234325
  285. 2b54: Human Cyclin Dependent Kinase 2 (ckd2)complexed with Din- 232305
  286. 2b55: Human Cyclin Dependent Kinase 2 (cdk2) Complexed with Indenopyraxole Din-101312
  287. 2b9f: Crystal Structure of Non-phosphorylated Fus3
  288. 2b9h: Crystal Structure of Fus3 with a Docking Motif from Ste7
  289. 2b9i: Crystal Structure of Fus3 with a Docking Motif from Msg5
  290. 2b9j: Crystal Structure of Fus3 with a Docking Motif from Far1
  291. 2baj: P38ALPHA Bound to Pyrazolourea
  292. 2bak: P38ALPHA Map Kinase Bound to Mpaq
  293. 2bal: P38ALPHA Map Kinase Bound to Pyrazoloamine
  294. 2baq: P38ALPHA Bound to Ro3201195
  295. 2bhe: Human Cyclin Dependent Protein Kinase 2 in Complex with The Inhibitor 5-bromo-indirubine
  296. 2bhh: Human Cyclin Dependent Protein Kinase 2 in Complex with The Inhibitor 4-hydroxypiperindinesulfonyl-indirubine
  297. 2bik: Human Pim1 Phosphorylated on Ser261
  298. 2bil: The Human Protein Kinase Pim1 in Complex with Its Consensus Peptide Pimtide
  299. 2biy: Structure of PDK1-S241A Mutant Kinase Domain
  300. 2bkz: Structure of Cdk2-cyclin a with Pha-404611
  301. 2bmc: Aurora-2 T287D T288D Complexed with Pha-680632
  302. 2bpm: Structure of Cdk2-cyclin a with Pha-630529
  303. 2br1: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  304. 2brb: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  305. 2brg: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  306. 2brh: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  307. 2brm: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  308. 2brn: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  309. 2bro: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  310. 2btr: Structure of Cdk2 Complexed with Pnu-198873
  311. 2bts: Structure of Cdk2 Complexed with Pnu-230032
  312. 2buj: Crystal Structure of The Human Serine-threonine Kinase 16 in Complex with Staurosporine
  313. 2bva: Crystal Structure of The Human P21-activated Kinase 4
  314. 2bzh: Crystal Structure of The Human Pim1 in Complex with a Ruthenium Organometallic Ligand Ru1
  315. 2bzi: Crystal Structure of The Human Pim1 in Complex with a Ruthenium Organometallic Ligand Ru2
  316. 2bzj: Crystal Structure of The Human Pim1 in Complex with a Ruthenium Organometallic Ligand Ru3
  317. 2bzk: Crystal Structure of The Human Pim1 in Complex with Amppnp and Pimtide
  318. 2c1a: Structure of Camp-dependent Protein Kinase Complexed with Isoquinoline-5-sulfonic Acid (2-(2-(4-chlorobenzyloxy) Ethylamino)ethyl)amide
  319. 2c1b: Structure of Camp-dependent Protein Kinase Complexed with ( 4r,2s)-5'-(4-(4-chlorobenzyloxy)pyrrolidin-2- Ylmethanesulfonyl)isoquinoline
  320. 2c30: Crystal Structure of The Human P21-activated Kinase 6
  321. 2c3i: Crystal Structure of Human Pim1 in Complex with Imidazopyridazin I
  322. 2c3j: Identification of a Buried Pocket for Potent and Selective Inhibition of Chk1: Prediction and Verification
  323. 2c3k: Identification of a Buried Pocket for Potent and Selective Inhibition of Chk1: Prediction and Verification
  324. 2c3l: Identification of a Buried Pocket for Potent and Selective Inhibition of Chk1: Prediction and Verification
  325. 2c4g: Structure of Cdk2-cyclin a with Pha-533514
  326. 2c5n: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
  327. 2c5o: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
  328. 2c5v: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
  329. 2c5x: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
  330. 2c5y: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
  331. 2c60: Crystal Structure of Human Mitogen-activated Protein Kinase Kinase Kinase 3 Isoform 2 Phox Domain at 1.25 a Resolution
  332. 2c68: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  333. 2c69: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  334. 2c6d: Aurora a Kinase Activated Mutant (T287D) in Complex with Adpnp
  335. 2c6e: Aurora a Kinase Activated Mutant (T287D) in Complex with a 5-aminopyrimidinyl Quinazoline Inhibitor
  336. 2c6i: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  337. 2c6k: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  338. 2c6l: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  339. 2c6m: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  340. 2c6o: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  341. 2c6t: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  342. 2cci: Crystal Structure of Phospho-cdk2 Cyclin a in Complex with a Peptide Containing Both The Substrate and Recruitment Sites of Cdc6
  343. 2cdz: Crystal Structure of The Human P21-activated Kinase 4 in Complex with CGP74514A
  344. 2cgu: Identification of Chemically Diverse Chk1 Inhibitors by Receptor-based Virtual Screening
  345. 2cgv: Identification of Chemically Diverse Chk1 Inhibitors by Receptor-based Virtual Screening
  346. 2cgw: Identification of Chemically Diverse Chk1 Inhibitors by Receptor-based Virtual Screening
  347. 2cgx: Identification of Chemically Diverse Chk1 Inhibitors by Receptor-based Virtual Screening
  348. 2cjm: Mechanism of Cdk Inhibition by Active Site Phosphorylation: Cdk2 Y15P T160P in Complex with Cyclin a Structure
  349. 2clx: 4-arylazo-3,5-diamino-1h-pyrazole Cdk Inhibitors: Sar Study, Crystal Structure in Complex with Cdk2, Selectivity, and Cellular Effects
  350. 2cos: Solution Structure of Rsgi Ruh-038, a Uba Domain from Mouse Lats2 (large Tumor Suppressor Homolog 2)
  351. 2cpk: Crystal Structure of The Catalytic Subunit of Cyclic Adenosine Monophosphate-dependent Protein Kinase
  352. 2cu1: Solution Structure of The Pb1 Domain of Human Protein Kinase MEKK2B
  353. 2df6: Crystal Structure of The Sh3 Domain of Betapix in Complex with a High Affinity Peptide from Pak2
  354. 2drn: Docking and Dimerization Domain (d/d) of The Type Ii-alpha Regulatory Subunity of Protein Kinase a (pka) in Complex with a Peptide from an A-kinase Anchoring Protein
  355. 2erz: Crystal Structure of C-amp Dependent Kinase (pka) Bound to Hydroxyfasudil
  356. 2esm: Crystal Structure of Rock 1 Bound to Fasudil
  357. 2etk: Crystal Structure of Rock 1 Bound to Hydroxyfasudil
  358. 2etr: Crystal Structure of Rock I Bound to Y-27632
  359. 2eu9: Crystal Structure of Clk3
  360. 2euf: X-ray Structure of Human Cdk6-vcyclin in Complex with The Inhibitor Pd0332991
  361. 2eva: Structural Basis for The Interaction of Tak1 Kinase with Its Activating Protein Tab1
  362. 2ewa: Dual Binding Mode of Pyridinylimidazole to Map Kinase P38
  363. 2exc: Inhibitor Complex of Jnk3
  364. 2exe: Crystal Structure of The Phosphorylated Clk3
  365. 2exm: Human Cdk2 in Complex with Isopentenyladenine
  366. 2ezw: Solution Structure of The Docking and Dimerization Domain of The Type I Alpha Regulatory Subunit of Protein Kinase a (rialpha D/d)
  367. 2f2c: X-ray Structure of Human Cdk6-vcyclinwith The Inhibitor Aminopurvalanol
  368. 2f2u: Crystal Structure of The Rho-kinase Kinase Domain
  369. 2f49: Crystal Structure of Fus3 in Complex with a Ste5 Peptide
  370. 2f57: Crystal Structure of The Human P21-activated Kinase 5
  371. 2f7e: Pka Complexed with (s)-2-(1h-indol-3-yl)-1-(5-isoquinolin-6- Yl-pyridin-3-yloxymethyl-etylamine
  372. 2f7x: Protein Kinase a Bound to (s)-2-(1h-indol-3-yl)-1-[5-((e)-2- Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
  373. 2f7z: Protein Kinase a Bound to (r)-1-(1h-indol-3-ylmethyl)-2-(2- Pyridin-4-yl-[1,7]naphtyridin-5-yloxy)-ehylamine
  374. 2f9g: Crystal Structure of Fus3 Phosphorylated on Tyr182
  375. 2fa2: Crystal Structure of Fus3 without a Peptide from Ste5
  376. 2fb8: Structure of The B-raf Kinase Domain Bound to Sb-590885
  377. 2fk9: Human Protein Kinase C, Eta
  378. 2fsl: Mitogen Activated Protein Kinase P38ALPHA (D176A+F327S) Activating Mutant Form-a
  379. 2fsm: Mitogen Activated Protein Kinase P38ALPHA (D176A+F327S) Activating Mutant Form-b
  380. 2fso: Mitogen Activated Protein Kinase P38ALPHA (D176A) Activating Mutant
  381. 2fst: Mitogen Activated Protein Kinase P38ALPHA (D176A+F327L) Activating Mutant
  382. 2fum: Catalytic Domain of Protein Kinase Pknb from Mycobacterium Tuberculosis in Complex with Mitoxantrone
  383. 2fvd: Cyclin Dependent Kinase 2 (cdk2) with Diaminopyrimidine Inhibitor
  384. 2fys: Crystal Structure of Erk2 Complex with Kim Peptide Derived from Mkp3
  385. 2g01: Pyrazoloquinolones as Novel, Selective Jnk1 Inhibitors
  386. 2g9x: Structure of Thr 160 Phosphorylated Cdk2/cyclin a in Complex with The Inhibitor Nu6271
  387. 2gbl: Crystal Structure of Full Length Circadian Clock Protein Kaic with Phosphorylation Sites
  388. 2gcd: Tao2 Kinase Domain-staurosporine Structure
  389. 2gdo: 4-(aminoalkylamino)-3-benzimidazole-quinolinones as Potent Chk1 Inhibitors
  390. 2gfc: Camp-dependent Protein Kinase Pka Catalytic Subunit with Pki-5-24
  391. 2gfs: P38 Kinase Crystal Structure in Complex with Ro3201195
  392. 2ghg: H-chk1 Complexed with A431994
  393. 2ghl: Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor Pg-874743
  394. 2ghm: Mutated Map Kinase P38 (mus Musculus) in Complex with Inhbitor Pg-895449
  395. 2gu8: Discovery of 2-pyrimidyl-5-amidothiophenes as Novel and Potent Inhibitors for Akt: Synthesis and Sar Studies
  396. 2h9r: Docking and Dimerization Domain (d/d) of The Regulatory Subunit of The Type Ii-alpha Camp-dependent Protein Kinase a Associated with a Peptide Derived from an A-kinase Anchoring Protein (akap)
  397. 2iw6: Structure of Human Thr160-phospho Cdk2-cyclin a Complexed with a Bisanilinopyrimidine Inhibitor
  398. 2iw8: Structure of Human Thr160-phospho Cdk2-cyclin a F82H-L83V- H84D Mutant with an O6-cyclohexylmethylguanine Inhibitor
  399. 2iw9: Structure of Human Thr160-phospho Cdk2-cyclin a Complexed with a Bisanilinopyrimidine Inhibitor
  400. 2j0i: Crystal Structure of The Human P21-activated Kinase 4
  401. 2j4z: Structure of Aurora-2 in Complex with Pha-680626
  402. 2j9m: Crystal Structure of Cdk2 in Complex with Macrocyclic Aminopyrimidine
  403. 3ndm: Crystal Structure of Rho-associated Protein Kinase (rock1) with a Potent Isoquinolone Derivative
  404. 2xix: Protein Kinase Pim-1 in Complex with Fragment-1 from Crystallographic Fragment Screen
  405. 2xiy: Protein Kinase Pim-1 in Complex with Fragment-2 from Crystallographic Fragment Screen
  406. 2xiz: Protein Kinase Pim-1 in Complex with Fragment-3 from Crystallographic Fragment Screen
  407. 2xj0: Protein Kinase Pim-1 in Complex with Fragment-4 from Crystallographic Fragment Screen
  408. 2xj1: Protein Kinase Pim-1 in Complex with Small Molecule Inibitor
  409. 3pna: Crystal Structure of Camp Bound (91-244)ria Subunit of Camp-dependent Protein Kinase
  410. 4a7c: Crystal Structure of Pim1 Kinase with Etp46546
  411. 4a9y: P38ALPHA Map Kinase Bound to Cmpd 8
  412. 4aa0: P38ALPHA Map Kinase Bound to Cmpd 2
  413. 4aa4: P38ALPHA Map Kinase Bound to Cmpd 22
  414. 4aa5: P38ALPHA Map Kinase Bound to Cmpd 33
  415. 4app: Crystal Structure of The Human P21-activated Kinase 4 in Complex with (s)-n-(5-(3-benzyl-1-methylpiperazine-4- Carbonyl)-6,6-dimethyl-1,4,5,6-tetrahydropyrrolo(3,4-c) Pyrazol-3-yl)-3-phenoxybenzamide
  416. 4alu: Benzofuropyrimidinone Inhibitors of Pim-1
  417. 4alv: Benzofuropyrimidinone Inhibitors of Pim-1
  418. 4alw: Benzofuropyrimidinone Inhibitors of Pim-1
  419. 4g1w: Crystal Structure of Jnk1 in Complex with Jip1 Peptide and 7-fluoro-3- [4-(2-hydroxy-ethanesulfonyl)-benzyl]-4-oxo-1-phenyl-1,4-dihydro- Quinoline-2-carboxylic Acid Methyl Ester
  420. 4hys: Crystal Structure of Jnk1 in Complex with Jip1 Peptide and 4-(4- Indazol-1-yl-pyrimidin-2-ylamino)-cyclohexan
  421. 4hyu: Crystal Structure of Jnk1 in Complex with Jip1 Peptide and 4-{4-[4-(3- Methanesulfonyl-propoxy)-indazol-1-yl]-pyrimidin-2-ylamino}- Cyclohexan
  422. 4izy: Crystal Structure of Jnk1 in Complex with Jip1 Peptide and 4-{4-[4-(4- Methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}- Cyclohexan
  423. 4oxj: Crystal Structure of Pvx_084705 in Presence of Compound 2
© Copyright 2008-2009 by enzymes.me.uk